Boston, 4 to 7 June 2018
PAT SA and its newly created subsidiary TEMISIS will be present at BIO International Convention from 4th to 7th June in Boston. Inescapable convention of pharmaceutical sector, this event gathers worldwide pharmaceutical players and biotechs that present their latest innovations. Dr. Paul Hannewald, COO, and Dr. Jean-François Ginglinger, Pharmaceutical API Dev. Manager, will represent PAT and its therapeutic subsidiary during the show.
TEM1657 (patent 2016), API developed at the preclinical with very promising results in the treatment of inflammatory skin deseases, that intend to go to 1st clinical stage soon.